Cite
HARVARD Citation
Zhang, H. et al. (2018). Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP3 inflammasome activation. Journal of cellular and molecular medicine. 22 (9), pp. 4437-4448. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, H. et al. (2018). Gypenosides improve diabetic cardiomyopathy by inhibiting ROS‐mediated NLRP3 inflammasome activation. Journal of cellular and molecular medicine. 22 (9), pp. 4437-4448. [Online].